MoonLake Immunotherapeutics（MLTX）價格預測MLTXMoonLake Immunotherapeutics

Alphio's MLTX stock price prediction model matches the current MoonLake Immunotherapeutics tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $15.04 (-0.05%). The 1-week path is $15.42 (+2.48%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

MoonLake Immunotherapeutics is currently a hold. The stock is priced at $14.99, significantly below analyst price targets of $50 and $70, indicating potential upside. However, the RSI is at a low 22.34, suggesting oversold conditions but also a lack of momentum. The company reported a narrower loss of $0.84 per share against an expected loss of $0.93, which is a positive sign, yet the overall financial performance shows consistent losses, with a net income of -69,707,000 in Q1 2026. The main risk is the ongoing negative earnings trend, with a projected loss of -61,805,000 in Q2 2026.

MoonLake Immunotherapeutics (MLTX) last closed at $15.05, gaining +0.40%. These facts feed the 1-day and 1-week MLTX price prediction above.